Hansa Biopharma AB
LSE:0RC7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hansa Biopharma AB
LSE:0RC7
|
SE |
|
A
|
Advantage Energy Ltd
OTC:AAVVF
|
CA |
|
Bucher Industries AG
F:BUHA
|
CH |
|
Blackrock Silver Corp
F:AHZ0
|
CA |
Wall St Price Targets
0RC7 Price Targets Summary
Hansa Biopharma AB
According to Wall Street analysts, the average 1-year price target for 0RC7 is 75.25 SEK with a low forecast of 36.63 SEK and a high forecast of 108.97 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RC7's stock price target?
Price Target
75.25
SEK
According to Wall Street analysts, the average 1-year price target for 0RC7 is 75.25 SEK with a low forecast of 36.63 SEK and a high forecast of 108.97 SEK.
What is the Revenue forecast for Hansa Biopharma AB?
Projected CAGR
50%
Over the last 13 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 8 years is 50%.
What is the Gross Profit forecast for Hansa Biopharma AB?
Projected CAGR
88%
The compound annual growth rate for Gross Profit over the next 3 years is 88%.
